Fact CheckerSign in

NCT05773885Completed

Telerehabilitation in People With Parkinson's Disease

Home Telerehabilitation Based on Serious Games for Continuity of Care in People With Parkinson's Disease

Source: ClinicalTrials.gov · Last updated 23 Oct 2026

Brief summary (registry, in English)

Although TeleRehabilitation (TR) is widely accepted as an appropriate model for the provision of professional health services in the field of physiotherapy, with already established standards, guidelines and policies, there are still few studies in the literature on the use of TR as a rehabilitation tool in people with Parkinson's Disease (PD). Therefore, further studies on the efficacy of TR in the management of motor and non-motor symptoms of PD are needed. The study TEMPO aims at assessing the efficacy (in terms of autonomy in carrying out the activities of daily life) of a home TR program based on serious games in people with PD compared to conventional day-hospital treatment.

Status (registry)
Completed
Study type
Interventional
Enrollment
58 (actual)
First submitted
3 Oct 2022
Start date
1 Sept 2022
Primary completion date
30 Mar 2025
Lead sponsor
IRCCS San Raffaele Roma
NCT number
NCT05773885

What you commit to

  • Study type: Interventional
  • Participants enrolled: 58
  • From 1 Sept 2022 to the primary completion date, 30 Mar 2025
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • other neurological pathologies, psychiatric complications or personality disorders;
  • musculoskeletal diseases that impair movement;
  • presence of cognitive impairment measured by the MoCA total score \< 18;
  • hearing and speech impairment affecting participation in the system;

Other

  • having any cognitive problems or low compliance that prevent using the TR system;
  • presence of dyskinesias assessed by the MDS-UPDRS with a score to items 4.1 and 4.2 \> 2;
  • severe cognitive or linguistic deficits (inability to understand and comply with study procedures);
  • presence of blurred or low vision problems;
  • absence of signature of the informed consent.

Who the study is looking for

  • age between 30 and 80 years;
  • diagnosis of Parkinson's Disease according to the "Movement Disorders Society's diagnostic criteria";
  • Hoehn \& Yahr (H\&Y) score between 2 and 3 (ON-state);
  • absence of dyskinesias assessed by the MDS-UPDRS with a score to items 4.1 and 4.2 ≤ 2;
  • absence of cognitive impairment measured by the MoCA total score ≥ 18;
  • stabilized drug treatment;
  • have access to the Internet for TR;
  • have a caregiver available during rehabilitation sessions in TR;
  • have sufficient cognitive and linguistic level to understand and comply with study procedures;
  • sign informed consent.

Age in the registry: 30 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
San Raffaele Cassino
Coordinator of this site? Confirm its status
CassinoItalyUnknown status
IRCCS San Raffaele Roma
Coordinator of this site? Confirm its status
RomeItalyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.